Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Medical oncology · Peking University People's Hospital · Beijing

Dr. Xie Lu谢璐

Associate Chief Physician · Associate Professor
Deputy department head

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Xie Lu

Professional overview

Xie Lu is an Associate Chief Physician and Associate Professor in the Department of Bone Tumor I at Peking University People's Hospital, specializing in drug therapy for bone and soft tissue sarcomas, including neoadjuvant and adjuvant chemotherapy for osteosarcoma and Ewing sarcoma.

SpecialtyMedical oncology
Clinical titleAssociate Chief Physician
Academic rolesAssociate Professor
DepartmentDepartment of Bone Tumor I
HospitalPeking University People's Hospital
CityBeijing
Hospital roleDeputy Director, Department of Bone Tumor II, Peking University People's Hospital

Department leadership

Deputy department head

A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.

Areas of focus

OsteosarcomaNeoadjuvant and adjuvant chemotherapy for newly diagnosed osteosarcoma
Ewing sarcomaFirst-line chemotherapy for newly diagnosed Ewing sarcoma and drug therapy after progression
Bone and soft tissue sarcomaSystemic planning of drug and surgical treatment strategies, including targeted and immunotherapy sequencing

Background

  • 2016Visiting scholar in Pediatric Oncology and Medical Oncology at Mayo Clinic, USA, focusing on medical treatment of bone and soft tissue sarcomas

Experience & recognition

  • 37 publications as first or corresponding author, including 33 SCI papers
  • Principal investigator of clinical trials in sarcoma drug therapy
  • Author of guidelines for managing drug-related toxicities in sarcoma treatment
  • Recipient of Peking University Outstanding Young Physician Award (2021)
  • Recipient of Peking University People's Hospital Outstanding Staff Award (2017)
  • Co-recipient of Second Prize of Science and Technology Progress Award, China Anti-Cancer Association

Professional roles

  • Member, Scientific Committee of ESMO Sarcoma Faculty (only representative from mainland China)
  • Member, MIB Osteosarcoma Group
  • Member, Children's Oncology Group (COG)
  • Member, EURO-Ewing Society
  • Member, European Organisation for Research and Treatment of Cancer (EORTC)
  • Member, EUROCAN
  • Young Editorial Board Member, Annals of Oncology
  • Deputy Leader, Drug and Precision Therapy Working Group, Bone Tumor and Bone Metastasis Society, China Anti-Cancer Association (CACA)

Frequently asked questions

What does Dr. Xie Lu specialize in?

Specializes in drug therapy for bone and soft tissue sarcomas, including neoadjuvant and adjuvant chemotherapy for osteosarcoma and Ewing sarcoma; systemic planning of drug and surgical treatment strategies; sequencing of targeted and immunotherapy.

Which hospital and department is Dr. Xie Lu in?

Department of Bone Tumor I at Peking University People's Hospital

Sources

Dr. Xie Lu has not reviewed this page.